In summary, our QM/MM study of the inhibition of M pro by two covalent (peptidyl) inhibitors, B3 and B4, which we designed based on medicinal chemistry experience and results derived from our previous computational studies, indicates that B4 could be used a template to redesign promising candidates as drug leads against COVID-19.